Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-a von Torres, D., Hou, X., Bale, L.K., Heinzen, E.P., Maurer, M.J., Zhang, Q., Conover, C.A., Weroha, S.J.

Volltext

Gemcitabine and novel Chk1 inhibitor GDC-0575 demonstrate synergistic effect against high-grade serous ovarian cancer in 3D cell culture, PDX models and patient tumors von DeJong, S.R., Hou, X., Zanfagnin, V., Evans, B.J., VanBlaricom, J., Epler, J., Nickles, D., Becker, M.A., Oberg, A.L., Heinzen, E.P., Blackwood, B., Haluska, P., Weroha, S.J.

Volltext